L&G Healthcare Breakthrough UCITS ETF (DOCG)
Category Sector Equity Healthcare
This ETF can be held in an Investment ISA, SIPP and Investment Account
Sell
883.10p
Buy
885.10p
-4.30p (-0.48%)
Prices updated at 24 Apr 2024, 16:11 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The investment objective of the Fund is to provide exposure to the global healthcare technology industry. In order to achieve this investment objective, the Fund will seek to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk profile
- Management
Company name
LGIM Managers (Europe) Limited
Brand name
Legal & General
Domicile
Ireland
Legal structure
Open Ended Investment Company
UCITS
Yes
Fiscal year end
June
Head office
33/34 Sir John Rogerson’s Quay
Ireland